Sinovac Biotech (SVA) Tops Q2 EPS by 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. TMUS
9. VZ
10. SPY

Go back to Sinovac Biotech (SVA) Tops Q2 EPS by 5c

Sinovac Reports Unaudited Second Quarter Financial Results

August 12, 2015 4:30 PM EDT

BEIJING, Aug.12, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter and half year financial results for the period ended June 30, 2015.

Second Quarter 2015 Financial Highlights (compared to the second quarter of 2014)

Quarterly sales were $18.5 million, an increase of 53.1% from $12.1 million in the prior year period. Gross profit was $15.1 million, an increase of 66.6% from $9.1 million in the prior year period. Gross margin was 81.6%, compared to 75.0% in the prior year period.... More